Latest Astex Stories
NEW YORK June 6, 2011 /PRNewswire/ -- SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced their June 2nd RetailInvestorConferences.com presentation is available for on-demand viewing.
NEW YORK, May 26, 2011 /PRNewswire/ -- SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., president and chief executive officer, will present at RetailInvestorConferences.com.
CAMBRIDGE, England, May 3, 2011 /PRNewswire-FirstCall/ -- Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved multiple early milestones in its fragment-based drug discovery collaboration with GlaxoSmithKline which commenced in November 2009.
Research and Markets (http://www.researchandmarkets.com/research/ab4b51/whos_developing_w) has announced the addition of the "Who's Developing What in Global Biopharmaceuticals?" report to their offering.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.